Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Cash from Operations (2020 - 2025)

Silence Therapeutics' Cash from Operations history spans 6 years, with the latest figure at 17287000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 37.09% to 17287000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 62271000.0, a 8.75% increase, with the full-year FY2025 number at 62271000.0, up 7.94% from a year prior.
  • Cash from Operations hit 17287000.0 in Q4 2025 for Silence Therapeutics, down from 10884000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for SLN hit a ceiling of 36384264.24 in Q2 2021 and a floor of 27481000.0 in Q4 2024.
  • Historically, Cash from Operations has averaged 11597208.68 across 5 years, with a median of 11696034.08 in 2022.
  • The widest YoY moves for Cash from Operations: up 67.53% in 2024, down 313.84% in 2024.
  • Tracing SLN's Cash from Operations over 5 years: stood at 8918438.18 in 2021, then tumbled by 76.34% to 15726622.93 in 2022, then increased by 6.35% to 14727508.27 in 2023, then plummeted by 86.6% to 27481000.0 in 2024, then skyrocketed by 37.09% to 17287000.0 in 2025.
  • Business Quant data shows Cash from Operations for SLN at 17287000.0 in Q4 2025, 10884000.0 in Q3 2025, and 21791000.0 in Q2 2025.